Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.56 | 0.78 | -28.15 |
| EPS, GAAP | 0.56 | 0.78 | 0.78 |
| Consensus Estimate | -0.24 | -0.15 | 65.52 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.17 | -0.59 | -128.12 |
| EPS, GAAP | 0.17 | -0.59 | -128.12 |
| Consensus Estimate | 0.17 | -0.52 | -132.69 |
| PCYC | Industry Average | |
| P/E (TTM) | 60.25 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.20 |
| Price/Sales | 32.37 | 18.91 |
| Beta | 0.65 | 0.70 |
| 9:13 AM | 3/8/2013 | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH |
| 6:35 AM | 3/8/2013 | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH |
| 3/8/2013 | Pharmacyclics Does Smart and Opportunistic Capital Raise After Huge Run Up (24/7 Wall St) |
| 2/28/2013 | ETF Folly: Biotech ETFs, Nothing but Confusion (24/7 Wall St) |
| 2/8/2013 | ??JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY) (24/7 Wall St) |
| 1/26/2013 | The Little Brokerage That Could (Barrons.com) |
| 1/15/2013 | Top Analyst Upgrades and Downgrades (AFL, AXP, AINV, ARMH, BIIB, CELG, CS, DELL, GMCR, INFY, LOGI, LYG, MLNX, NKTR, PDLI, PCYC, REGN, RBS, UAL, LCC, VRTX, VPHM, WFT) (24/7 Wall St) |
